In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes

Journal of Investigative Dermatology

Volumn 110, Issue 6, 1998, Pages 889-893

  Shimada, Akemi ^a   Ota, Yukiko ^a   Sugiyama, Yoshinori ^a   Sato, Sayuri ^b   Kume, Kazuhiko ^b   Shimizu, Takao ^b   Inoue, Shintaro ^a  

^a KANEBO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cornified envelope; PAFR antagonist; WEB 2086

Indexed keywords

APAFANT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR AFFECTING AGENT;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH CURVE; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION;

EID: 0031808704     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00202.x     Document Type: Article

References (47)

1. Baldi E, Bonaccorsi L, Finetti G, et al: Platelet-activating factor in human endometrium. J Steroid Biochem Molec Biol 49:359-363, 1994
2. Behrens TW, Goodwin JS: Control of human T cell proliferation by platelet-activating factor. Int J Immunopharmacol 12:175-184, 1990
3. Bito H, Honda Z-i, Nakamura M, Shimizu T: Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem 221:211-218, 1994
4. Boyce ST, Ham RG: Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81 (Suppl.):33S-40S, 1983
5. Boyce ST, Ham RG: Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free medium. J Tissue Culture Meth 9:83-93, 1985
6. Casals-Stenzel J: Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol 133:117-122, 1987
7. Chao W, Olson MS: Platelet-activating factor: receptors and signal transduction. Biochem J 292:617-629, 1993
8. 32P-based hybridizations. Anal Biochem 210:235-244, 1993
9. Grandel KE, Farr RS, Wanderer AA, Eisenstadt TC, Wasserman SI: Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 313:405-409, 1985
10. Guinot P, Summerhayes C, Berdah L, Duchier J, Revillaud RJ: Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN 52063. Lancet ii:114, 1988
11. Hanahan DJ: Platelet activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 55:483-509, 1986
12. Honda Z-i, Nakamura M, Miki I, et al: Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349:342-346, 1991
13. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, Takehara K: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105:280-284, 1995
14. Ishii S, Matsuda Y, Nakamura M, Waga I, Kume K, Izumi T, Shimizu T: A murine platelet-activating factor receptor gene: cloning, chromosomal isolation and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem J 314:671-678, 1996
15. Ishii S, Nagase T, Tashiro F, et al: Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 16:133-142, 1997
16. Itano N, Kimata K: Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J Biol Chem 271:9875-9878, 1996
17. Izumi T, Shimizu T: Platelet-activating factor receptor: gene expression and signal transductron. Biochim Biophys Acta 1259:317-333, 1995
18. Izumi T, Kishimoto S, Takano T, et al: Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochem J 305:829-835, 1995
19. Kato K, Clark GD, Bazan NG, Zorumski CF: Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367:175-179, 1994
20. Komuro Y, Imanishi N, Uchida M, Morooka S: Biological effect of orally active platelet-activating factor receptor antagonist SM-10661. Mol Pharmacol 38:378-384, 1990
21. Kume K, Shimizu T: Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor. J Biol Chem 272:22898-22904, 1997
22. Kunz D, Gerard NP, Gerard C: The human leukocyte platelet-activating factor receptor: cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem 267:9101-9106, 1992
23. Lavand P, Rodrigue F, Carré C, Touvay C, Mencia-Huerta JM, Braquet P: Pharmacologic modulation of picryl chloride-induced contact dermatitis m the mouse. J Invest Dermatol 97:101-105, 1991
24. Leprince C, Vivier E, Treton D, Galanaud P, Benveniste J, Richard Y, Thomas Y: Immumoregulatory functions of paf-acether. VI. Dual effect on human B cell proliferation. Lipids 26:1204-1208, 1991
25. Liu B-J, Zheng M-R, Zhang S-Z, Dai F-P: Effects of antipsoriatic drugs on biosynthesis of platelet activating factor by human keratinocytes. Clin Med J 107:326-331, 1994
26. Mallet AI, Cunningham FM: Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun 126:192-198, 1985
27. Mallet AI, Cunningham FM, Daniel R: Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin. J Chromatogr 309:160-164, 1984
28. Marcelo CL, Duell EA, Rhodes LM, Dunham WR: In vitro model of essential fatty acid deficiency. J Invest Dermatol 99:703-708, 1992
29. Marcelo CL, Rhodes LM, Dunham WR: Normarization of essential-fatty-acid-deficient keratniocytes requires palmitic acid. J Invest Dermatol 103:564-568, 1994
30. Massey CV, Kohout TA, Gaa ST, Lederer WJ, Rogers TB: Molecular and cellular actions of platelet-activating factor in rat heart cells. J Clin Invest 88:2106-2116, 1991
31. Michel L, Denizot Y, Thomas Y, Jean-Louis F, Pitton C, Benveniste J, Dubertret L: Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. J Immunol 141:948-953, 1988
32. Michel L, Denizot Y, Thomas Y, Jean-Louis F, Heslan M, Benveniste J, Dubertret L: Production of paf-acether by human epidermal cells. J Invest Dermatol 95:576-581, 1990
33. Mori M, Aihara M, Kume K, Hamanoue M, Kohsaka S, Shimizu T: Predominant expression of platelet-activating factor receptor in the rat brain microglia. J Neurosci 16:3590-3600, 1996
34. Mutoh H, Bito H, Minami M, et al: Two different promotors direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. FEBS letters 322:129-134, 1993
35. Nakamura M, Honda Z-i, Izumi T, et al: Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 266:20400-20405, 1991
36. O'Neill C: Embryo-derived platelet activating factor. Reprod Fertil Dev 4:283-288, 1992
37. Okamoto M, Yoshida K, Uchida I, Nishikawa M, Kohsaka M, Aoki H: Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis (metylthio) gliotoxin and its derivatives. Chem Pharm Bull 34:340-344, 1986
38. Quellet S, Müller E, Rola-Pleszczynski M: IFN-γ up-regulates platelet-activating factor receptor gene expression in human monocytes. J Immunol 152:5092-5099, 1994
39. Prescott SM, Zimmerman GA, McIntyre TM: Platelet-activating factor. J Biol Chem 265:17381-17384, 1990
40. Rayner TE, Menadue MF, Oliver JR: Platelet-activating factor stimulates the release of atrial natriuretic factor from the rat heart. J Endocrinol 130:281-288, 1991
41. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, Perruchoud AP, Simon HU: Plate let-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 184:191-201, 1996
42. Sugimoto T, Tsuchimochi H, McGregor CGA, Mutoh H, Shimizu T, Kurachi Y: Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart. Biochem Biophys Res Commun 189:617-624, 1992
43. 3H] - platelet activating factor (PAF) to the platelet. Biochem Pharmacol 34:1491-1495, 1985
44. Tokumura A, Homma H, Hanahan DJ: Structural analogs of alkylacetylglycerophosphocholine inhibitory behavior on platelet activation. J Biol Chem 260:12710-12714, 1985
45. Travers JB, Huff C, Rola-Pleszczynski M, Gelfand EW, Morelli JG, Murphy RC: Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816-823, 1995
46. Travers JB, Harrison KA, Jhonson CA, Clay KL, Morelli JG, Murphy RC: Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J Invest Dermatol 107:88-94, 1996
47. Ye RD, Prossnitz ER, Zou A, Cochrane CG: Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun 180:105-111, 1991